The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Charles Q. Meng

AtheroGenics

Inc., 8995 Westside Parkway

Alpharetta

USA

[email]@atherogenics.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • AtheroGenics, Inc., 8995 Westside Parkway, Alpharetta, USA. 2001 - 2007
  • AtheroGenics Inc, Alpharetta, GA 30004, USA. 2001 - 2002
  • NPS Allelix Corp., Mississauga, Ontario, Canada. 2000

References

  1. Carboxylated, heteroaryl-substituted chalcones as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseases. Meng, C.Q., Ni, L., Worsencroft, K.J., Ye, Z., Weingarten, M.D., Simpson, J.E., Skudlarek, J.W., Marino, E.M., Suen, K.L., Kunsch, C., Souder, A., Howard, R.B., Sundell, C.L., Wasserman, M.A., Sikorski, J.A. J. Med. Chem. (2007) [Pubmed]
  2. Atherosclerosis is an inflammatory disorder after all. Meng, C.Q. Curr. Top. Med. Chem (2006) [Pubmed]
  3. Inflammation in atherosclerosis: new opportunities for drug discovery. Meng, C.Q. Mini. Rev. Med. Chem (2005) [Pubmed]
  4. Discovery of novel heteroaryl-substituted chalcones as inhibitors of TNF-alpha-induced VCAM-1 expression. Meng, C.Q., Zheng, X.S., Ni, L., Ye, Z., Simpson, J.E., Worsencroft, K.J., Hotema, M.R., Weingarten, M.D., Skudlarek, J.W., Gilmore, J.M., Hoong, L.K., Hill, R.R., Marino, E.M., Suen, K.L., Kunsch, C., Wasserman, M.A., Sikorski, J.A. Bioorg. Med. Chem. Lett. (2004) [Pubmed]
  5. Discovery of novel phenolic antioxidants as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseases. Meng, C.Q., Somers, P.K., Hoong, L.K., Zheng, X.S., Ye, Z., Worsencroft, K.J., Simpson, J.E., Hotema, M.R., Weingarten, M.D., MacDOnald, M.L., Hill, R.R., Marino, E.M., Suen, K.L., Luchoomun, J., Kunsch, C., Landers, L.K., Stefanopoulos, D., Howard, R.B., Sundell, C.L., Saxena, U., Wasserman, M.A., Sikorski, J.A. J. Med. Chem. (2004) [Pubmed]
  6. BO-653. Chugai. Meng, C.Q. Curr. Opin. Investig. Drugs (2003) [Pubmed]
  7. HDL Cholesterol 2003--Fourth Annual International Conference. Metabolic pathways and drug targets. 2-4 March 2003, Cambridge, MA, USA. Meng, C.Q. IDrugs (2003) [Pubmed]
  8. Ezetimibe. Schering-Plough. Meng, C.Q. Curr. Opin. Investig. Drugs (2002) [Pubmed]
  9. Novel phenolic antioxidants as multifunctional inhibitors of inducible VCAM-1 expression for use in atherosclerosis. Meng, C.Q., Somers, P.K., Rachita, C.L., Holt, L.A., Hoong, L.K., Zheng, X.S., Simpson, J.E., Hill, R.R., Olliff, L.K., Kunsch, C., Sundell, C.L., Parthasarathy, S., Saxena, U., Sikorski, J.A., Wasserman, M.A. Bioorg. Med. Chem. Lett. (2002) [Pubmed]
  10. Nitrobenzene compounds inhibit expression of VCAM-1. Meng, C.Q., Zheng, X.S., Holt, L.A., Hoong, L.K., Somers, P.K., Hill, R.R., Saxena, U. Bioorg. Med. Chem. Lett. (2001) [Pubmed]
  11. Ezetimibe (Schering-Plough). Meng, C.Q. Curr. Opin. Investig. Drugs (2001) [Pubmed]
  12. Restenosis drug discovery--a formidable task. Meng, C.Q. Curr. Opin. Investig. Drugs (2001) [Pubmed]
  13. 5-Thienyltryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: potential treatments for migraine. Meng, C.Q., Rakhit, S., Lee, D.K., Kamboj, R., McCallum, K.L., Mazzocco, L., Dyne, K., Slassi, A. Bioorg. Med. Chem. Lett. (2000) [Pubmed]
 
WikiGenes - Universities